CS441388A3 - Pharmaceutical antiviral preparation - Google Patents

Pharmaceutical antiviral preparation

Info

Publication number
CS441388A3
CS441388A3 CS884413A CS441388A CS441388A3 CS 441388 A3 CS441388 A3 CS 441388A3 CS 884413 A CS884413 A CS 884413A CS 441388 A CS441388 A CS 441388A CS 441388 A3 CS441388 A3 CS 441388A3
Authority
CS
Czechoslovakia
Prior art keywords
antiviral preparation
pharmaceutical antiviral
pharmaceutical
preparation
antiviral
Prior art date
Application number
CS884413A
Other languages
English (en)
Other versions
CS276467B6 (en
Inventor
Anna Dr Szabolcs
Laszlo Dr Otvos
Janos Dr Sagi
Helga Dr Tudos
Attila Dr Szemzo
Zsuzsa Dr Veres
Istvan Dr Szinai
Miklos Dr Vajda
Istvan Csernus
Katalin Dr Marossy
Sandor Dr Jancso
Eva Dr Medgyesi
Gyorgy Dr Bacsa
Original Assignee
Mta Koezponti Kemiai Kutato In
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mta Koezponti Kemiai Kutato In, Biogal Gyogyszergyar filed Critical Mta Koezponti Kemiai Kutato In
Publication of CS441388A3 publication Critical patent/CS441388A3/cs
Publication of CS276467B6 publication Critical patent/CS276467B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS884413A 1987-08-07 1988-06-23 Pharmaceutical antiviral preparation CS276467B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873596A HU196038B (en) 1987-08-07 1987-08-07 Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine

Publications (2)

Publication Number Publication Date
CS441388A3 true CS441388A3 (en) 1992-01-15
CS276467B6 CS276467B6 (en) 1992-06-17

Family

ID=10964716

Family Applications (1)

Application Number Title Priority Date Filing Date
CS884413A CS276467B6 (en) 1987-08-07 1988-06-23 Pharmaceutical antiviral preparation

Country Status (25)

Country Link
US (2) US4880785A (cs)
JP (1) JPS6442437A (cs)
KR (1) KR960015953B1 (cs)
CN (1) CN1034133A (cs)
AU (1) AU605875B2 (cs)
BE (1) BE1001774A4 (cs)
CA (1) CA1286227C (cs)
CH (1) CH675538A5 (cs)
CS (1) CS276467B6 (cs)
CY (1) CY1655A (cs)
DD (1) DD270656A5 (cs)
DE (1) DE3820270A1 (cs)
DK (1) DK299088A (cs)
ES (1) ES2010559A6 (cs)
FI (1) FI883692A (cs)
FR (1) FR2619010B1 (cs)
GB (1) GB2207864B (cs)
GR (1) GR1000139B (cs)
HU (1) HU196038B (cs)
IT (1) IT1217789B (cs)
NL (1) NL8801411A (cs)
NO (1) NO882491L (cs)
RU (1) RU2035180C1 (cs)
SE (1) SE503261C2 (cs)
SG (1) SG42292G (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918260A1 (de) * 1979-05-07 1980-11-27 Robugen Gmbh Anwendung von 5-alkyl-2'-desoxyuridinen
DE3010397A1 (de) * 1980-03-18 1981-10-29 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
WO1983000436A1 (en) * 1981-08-04 1983-02-17 Gauri, Kailash, Kumar Combined preparation with synergic effect
AU575918B2 (en) * 1984-03-06 1988-08-11 Sloan-Kettering Institute For Cancer Research Hepatitis treatment with pyrimidine nucleoside compounds
HU197837B (en) * 1984-12-29 1989-06-28 Mta Koezponti Kemiai Kutato In Composition with skin cleaning effect, particularly for treating pimpled skin of face

Also Published As

Publication number Publication date
CN1034133A (zh) 1989-07-26
GB2207864B (en) 1992-01-15
IT1217789B (it) 1990-03-30
DK299088A (da) 1989-02-08
HU196038B (en) 1988-09-28
US4937233A (en) 1990-06-26
AU605875B2 (en) 1991-01-24
CA1286227C (en) 1991-07-16
IT8820871A0 (it) 1988-06-06
CY1655A (en) 1993-05-14
JPS6442437A (en) 1989-02-14
SE8802193L (sv) 1989-02-08
NO882491L (no) 1989-02-08
GR1000139B (el) 1991-09-27
SE8802193D0 (sv) 1988-06-13
AU1741388A (en) 1989-02-09
ES2010559A6 (es) 1989-11-16
KR890003380A (ko) 1989-04-14
RU2035180C1 (ru) 1995-05-20
NL8801411A (nl) 1989-03-01
FR2619010A1 (fr) 1989-02-10
FI883692A (fi) 1989-02-08
CS276467B6 (en) 1992-06-17
GR880100417A (en) 1989-05-25
BE1001774A4 (fr) 1990-03-06
GB8813392D0 (en) 1988-07-13
US4880785A (en) 1989-11-14
DK299088D0 (da) 1988-06-02
SG42292G (en) 1992-09-04
FI883692A0 (fi) 1988-08-08
DE3820270A1 (de) 1989-02-16
FR2619010B1 (fr) 1992-02-14
SE503261C2 (sv) 1996-04-29
KR960015953B1 (ko) 1996-11-25
GB2207864A (en) 1989-02-15
JPH0515694B2 (cs) 1993-03-02
NO882491D0 (no) 1988-06-06
DD270656A5 (de) 1989-08-09
CH675538A5 (cs) 1990-10-15

Similar Documents

Publication Publication Date Title
GB8610572D0 (en) Pharmaceutical preparation
CS403391A3 (en) Pharmaceutical
GB8716904D0 (en) Stable pharmaceutical preparation
GR862727B (en) Pharmaceutical preparation
CS8700282A2 (en) Nicorandil-containing stable pharmaceutical
GB8607817D0 (en) Drug preparation
GB8500310D0 (en) Pharmaceutical preparation
CS441388A3 (en) Pharmaceutical antiviral preparation
GB8721313D0 (en) Pharmaceutical preparation
ZA899948B (en) Pharmaceutical preparation
GB8712240D0 (en) Pharmaceutical formulation
EG18240A (en) New pharmaceutical preparation
HRP920590B1 (en) New pharmaceutical preparation
EG18297A (en) New drug preparation
HRP920593B1 (en) New drug preparation
BG43026A1 (en) Lyposomic pharmaceutical form
GB8707418D0 (en) Pharmaceutical formulations
GB8708527D0 (en) Pharmaceutical formulations
GB8704774D0 (en) Pharmaceutical formulations
GB8707417D0 (en) Pharmaceutical formulations
GB8707419D0 (en) Pharmaceutical formulations
GB8723862D0 (en) Pharmaceutical formulations
GB8720485D0 (en) Pharmaceutical formulations
GB8707420D0 (en) Pharmaceutical formulations
GB8708528D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20050623